Article info

Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development

Authors

  1. Correspondence to Dr Vivianne Malmström, Department of Medicine (Solna), Karolinska Universitetssjukhuset i Solna, Stockholm, 171 64, Sweden; vivianne.malmstrom{at}ki.se; Dr Bruno Raposo, Department of Medicine (Solna), Karolinska Universitetssjukhuset i Solna, Stockholm, 171 64, Sweden; bruno.raposo{at}ki.se
View Full Text

Citation

Raposo B, Afonso M, Israelsson L, et al
Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development

Publication history

  • Received September 30, 2022
  • Accepted December 28, 2022
  • First published January 5, 2023.
Online issue publication 
October 18, 2023
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.